Euroapi Company Header Euroapi Company Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Exacis Biotherapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Exacis Biotherapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1035 Cambridge Street, Suite 17B Cambridge MA 02141
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The acquisition includes global immuno-oncology platform of Exacis and its entire pipeline of engineered cell therapy programs for hematologic and solid tumors. Eterna will produce an unlimited number of mRNA-engineered NK and T-cell therapies derived from iPSCs.


Lead Product(s): iPSC-based Therapy

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: N/AProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Eterna Therapeutics

Deal Size: $49.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition May 02, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY